OpenLegislation

Regulation 4 The National Health Service (Wales) Act 2006I1

United Kingdom

(1)

The NHS (Wales) Act is amended as follows.

(2)

In section 46 (GMS contracts: prescription of drugs, etc)—

(a)

in subsection (3), for “Community marketing authorization or United Kingdom” substitute “ UK ”;

(b)

for subsection (4) substitute—

“(4)

“UK marketing authorisation” has the meaning given by regulation 8(1) of the Human Medicines Regulations 2012 (S.I. 2012/1916).”.

(3)

Omit the following provisions—

(a)

section 6A (reimbursement of cost of services provided in another EEA state) M1;

(b)

section 6B (prior authorisation for the purposes of section 6A) M2;

(c)

section 6BA (reimbursement of cost of services provided in another EEA state where expenditure incurred on or after 25 October 2013) M3;

(d)

section 6BB (prior authorisation for the purposes of section 6BA) M4;

(e)

section 131(a)(ii) (payment of travelling expenses) M5;

(f)

the definition of “Regulation (EC) No. 883/2004” in section 206(1) (interpretation) M6 except in so far as it relates to section 131(a)(iii).

Annotations

Marginal citations

M1

Section 6A was inserted by S.I. 2010/915 and amended by S.I. 2013/2269.

M2

Section 6B was inserted by S.I. 2010/915 and amended by S.I. 2013/2269.

M3

Section 6BA was inserted by S.I. 2013/2269.

M4

Section 6BB was inserted by S.I. 2013/2269.

M5

Section 131(a) was substituted by S.I. 2010/915 and amended by S.I. 2013/2269.

M6

The definition was inserted by S.I. 2010/915.

Commencement

I1

Reg. 4 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(1)